These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 25796382

  • 41. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
    Weintraub L, Weiner C, Miloh T, Tomaino J, Joashi U, Benchimol C, Strauchen J, Roth M, Wistinghausen B.
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
    [Abstract] [Full Text] [Related]

  • 42. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
    Ekman-Joelsson BM, Wåhlander H, Synnergren M, Sager M, Mellgren K.
    Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
    [Abstract] [Full Text] [Related]

  • 43. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese F, Caforio A, Menin C, Canova D, Farinati F, Luciana Aversa SM.
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [Abstract] [Full Text] [Related]

  • 44. Contrast patterns of Cytomegalovirus and Epstein-Barr virus infection in pediatric living-donor liver transplant recipients.
    Nafady-Hego H, Elgendy H, Uemoto S.
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():75-82. PubMed ID: 25894132
    [Abstract] [Full Text] [Related]

  • 45. Incidental EBV-positivity in paediatric post-transplant specimens demonstrates the need for stringent criteria for diagnosing post-transplant lymphoproliferative disorders.
    King RL, Paessler ME, Howard MT, Wertheim GB.
    J Clin Pathol; 2017 Mar; 70(3):270-273. PubMed ID: 27852687
    [Abstract] [Full Text] [Related]

  • 46. Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review.
    Stanley K, Friehling E, Ranganathan S, Mazariegos G, McAllister-Lucas LM, Sindhi R.
    Pediatr Transplant; 2018 Aug; 22(5):e13211. PubMed ID: 29745058
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
    Weiner C, Weintraub L, Wistinghausen B, Tomaino J, Arnon R, Kerkar N, Miloh T.
    Pediatr Transplant; 2012 Aug; 16(5):458-64. PubMed ID: 22554096
    [Abstract] [Full Text] [Related]

  • 51. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
    Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M.
    Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
    [Abstract] [Full Text] [Related]

  • 52. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K.
    Scand J Infect Dis; 2007 Oct; 39(3):235-44. PubMed ID: 17366054
    [Abstract] [Full Text] [Related]

  • 53. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Oct; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 54. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
    Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.
    Hepatogastroenterology; 2000 Oct; 47(31):211-9. PubMed ID: 10690611
    [Abstract] [Full Text] [Related]

  • 55. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 56. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 57. The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Vali R, Punnett A, Bajno L, Moineddin R, Shammas A.
    Pediatr Transplant; 2015 Dec; 19(8):932-9. PubMed ID: 26515450
    [Abstract] [Full Text] [Related]

  • 58. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B, Kropshofer G, Ellemunter H, Brunner A, Mueller T, Margreiter R, Tzankov A.
    Pediatr Transplant; 2007 Aug; 11(5):547-51. PubMed ID: 17631026
    [Abstract] [Full Text] [Related]

  • 59. The effectiveness of tonsillectomy in diagnosing lymphoproliferative disease in pediatric patients after liver transplantation.
    Broughton S, McClay JE, Murray A, Timmons C, Sommerauer J, Andrews W, Harkins P.
    Arch Otolaryngol Head Neck Surg; 2000 Dec; 126(12):1444-7. PubMed ID: 11115279
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.